Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
570-01-166 ISMRM Abstract

An interpretable machine learning model in predicting neoadjuvant chemoradiotherapy response using multiparametric MRI

Primary: Body - Pelvis
Secondary: Analysis Methods - Radiomics
570-01-166 · AI Applications in Body MRI · Wednesday, 13 May, 8:20 AM–9:15 AM · Traditional Posters | Exhibition Hall
Keywords: Radiomics Locally advanced rectal cancer Multiparametric MRI Nomogram SHAP Analysis
Accepted
xuemeng Li1,2, Fei Gao 3
1Department of Radiology,, The First Affiliated Hospital of USTC, Hefei, China
2Graduate School, Bengbu Medical University, China
3Department of Radiology, The First Affiliated Hospital of USTC, Hefei, China
Presenting Author: Fei Gao

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-63.DOI:10.3322/caac.21834. [doi]
2. BENSON A B, VENOOK A P, AL-HAWARY M M, et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw, 2022, 20(10): 1139-67.DOI:10.6004/jnccn.2022.0051. [doi]
3. GANI C, FOKAS E, POLAT B, et al. Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial [J]. Lancet Gastroenterol Hepatol, 2025, 10(6): 562-72.DOI:10.1016/S2468-1253(25)00049-4. [doi]
4. PATIL P S, SAKLANI A, KUMAR N A N, et al. A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer [J]. Front Oncol, 2025, 15: 1450602.DOI:10.3389/fonc.2025.1450602. [doi]
5. MIRANDA J, CAUSA ANDRIEU P, NINCEVIC J, et al. Advances in MRI-Based Assessment of Rectal Cancer Post-Neoadjuvant Therapy: A Comprehensive Review [J]. J Clin Med, 2023, 13(1).DOI:10.3390/jcm13010172. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/570-01-166